1. Home
  2. MGY vs GRFS Comparison

MGY vs GRFS Comparison

Compare MGY & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Magnolia Oil & Gas Corporation

MGY

Magnolia Oil & Gas Corporation

HOLD

Current Price

$24.23

Market Cap

4.8B

Sector

Energy

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$7.36

Market Cap

5.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGY
GRFS
Founded
2017
1940
Country
United States
Spain
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
5.0B
IPO Year
2017
2008

Fundamental Metrics

Financial Performance
Metric
MGY
GRFS
Price
$24.23
$7.36
Analyst Decision
Buy
Hold
Analyst Count
15
2
Target Price
$30.36
$10.15
AVG Volume (30 Days)
3.4M
359.7K
Earning Date
05-06-2026
07-28-2022
Dividend Yield
2.18%
1.80%
EPS Growth
N/A
N/A
EPS
0.24
N/A
Revenue
$1,311,845,000.00
N/A
Revenue This Year
$14.65
$4.49
Revenue Next Year
$1.99
$6.42
P/E Ratio
$104.81
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$21.07
$6.96
52 Week High
$32.76
$10.23

Technical Indicators

Market Signals
Indicator
MGY
GRFS
Relative Strength Index (RSI) 35.00 36.36
Support Level $23.53 $7.26
Resistance Level $27.96 $8.41
Average True Range (ATR) 0.81 0.12
MACD -0.37 -0.05
Stochastic Oscillator 0.99 5.84

Price Performance

Historical Comparison
MGY
GRFS

About MGY Magnolia Oil & Gas Corporation

Magnolia Oil & Gas Corp is an independent oil and natural gas company engaged in the acquisition, development, exploration, and production of oil, natural gas, and natural gas liquids (NGL) reserves. The company's oil and natural gas properties are located in Karnes County and the Giddings area of South Texas, where it targets the Eagle Ford Shale and Austin Chalk formations. It focuses on generating value for shareholders by delivering steady, moderate annual production growth resulting from its capital spending philosophy. The company operates in only one segment and derives the majority of its revenue from the sale of crude oil, natural gas, and natural gas liquids (NGLs).

About GRFS Grifols S.A.

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Share on Social Networks: